The Association between The Digestive System and Liver Injury in Covid-19 Patients

Mustapha Ismael Muhmmed(1), Aliaa Saadon Abdul-Razaq(2), Saad Mukhlif Mahdi(3),


(1) University of Baghdad
(2) University of Baghdad
(3) Anbar University
Corresponding Author

Abstract


The increasing number of cases infected with COVID-19 present not only respiratory symptoms but also diarrhea, vomiting, nausea, or abdominal discomfort. Patients who exhibit these symptoms should not be disregarded, and the absence of respiratory manifestations must not rule out COVID-19 infection. We tend to investigate the complications of the digestive system and liver injury for Iraqi patients infected with the COVID-19 virus. We compared the clinical data with two main groups of patients infected. One of them with digestive problems and the other without digestive problems. Several parameters were analyzed: Body Mass Index (BMI), Glutamic Pyruvic Transaminase (GPT), Glutamic-Oxaloacetic Transaminase (GOT), Total Serum Bilirubin (TSB), Anaplastic Lymphoma Kinase (ALK), and Immunoglobulin M (IgM). We classified into several types of patients: G1 (patients without digestive problems who were infected with COVID-19) and G2 (patients with digestive problems while infected with the COVID-19 virus). Each group was compared with two control groups of non-infected individuals. A total of 237 patients were included in the study. The control groups were divided according to obesity by measuring the BMI. The two main groups were compared with two control groups. The study of a patient with different BMI levels shows that most infected patients with high BMI come with gastrointestinal symptoms stronger than respiratory symptoms.

Keywords


Body mass index, COVID-19, IgG, IgM, Liver enzymes

References


Abbas, S. H., Hussein, Z. A., and Sumaiyahafet, W. A. (2019). study effect of cigarette smoking on the liverenzymes. International Journal of Pharmaceutical Research, 11(4), 1-5.

Ahmed, S., Faiq, A. B., Hama, A. A., and Salih, A. H. (2021). prevalence rate and correlation between triglyceride level and human body mass index in Sulaimani Province, Iraq. Iraqi Journal of Science, 62(5), 1423-1430.

Ahmed, Sr, S., Shaikh, H., Jamil, S., Ali, H., and Abbasi Jr, M. (2020). Impact of body mass index on gastrointestinal disorders: A cross-sectional study in a Pakistani population. Cureus, 12(4), 1-5.

Al-Bayati, A. M., Alwan, A. H., and Fadhil, H. Y. (2022). Potential role of TLR3 and RIG-I genes expression in surviving covid-19 patients with different severity of infection. Iraqi Journal of Science, 63(7), 2873-2883.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., and Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507-513.

Easom, N., Moss, P., Barlow, G., Samson, A., Taynton, T., Adams, K., and Lillie, P. J. (2020). Sixty‐eight consecutive patients assessed for COVID‐19 infection: Experience from a UK regional infectious diseases unit. Influenza and Other Respiratory Viruses, 14(4), 374-379.

Gu, J., Han, B., and Wang, J. (2020). COVID-19: Gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology, 158(6), 1518-1519.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., and Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.

Kareem, A. M., and Al-Azzawi, S. N. (2021). A stochastic differential equations model for the spread of coronavirus COVID-19): The case of Iraq. Iraqi Journal of Science, 62(3) 1025-

Kulkarni, A. V., Kumar, P., Tevethia, H. V., Premkumar, M., Arab, J. P., Candia, R., and Reddy, D. N. (2020). Systematic review with meta‐analysis: Liver manifestations and outcomes in COVID‐19. Alimentary Pharmacology and Therapeutics, 52(4), 584-599.

Liang, W., Feng, Z., Rao, S., Xiao, C., Xue, X., Lin, Z., and Qi, W. (2020). Diarrhoea may be underestimated: A missing link in 2019 novel coronavirus. Gut, 69(6), 1141-1143.

Razooki, H, H., White, D. A., and Mayer, R. J. (1982). Extensive destruction of newly synthesized casein in mammary explants in organ culture. Biochemical Journal, 202(1), 133-138.

Smyk, W., Janik, M. K., Portincasa, P., Milkiewicz, P., Lammert, F., and Krawczyk, M. (2020). COVID‐19: focus on the lungs but do not forget the gastrointestinal tract. European Journal of Clinical Investigation, 50(9), 1-7.

Song, Y., Liu, P., Shi, X. L., Chu, Y. L., Zhang, J., Xia, J., and Wang, M. Y. (2020). SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut, 69(6), 1143-1144.

Vollet-Filho, J. D., Ferreira-Strixino, J., Correa, R. B., Bagnato, V. S., and Kurachi, C. (2022). Fluorescence spectroscopy for clinical transplantation liver grafts monitoring: possibilities offered by 408 nm excitation. Acta Cirúrgica Brasileira, 37(9), 1-10.

Wang, Z., Yang, B., Li, Q., Wen, L., and Zhang, R. (2020). Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clinical Infectious Diseases, 71(15), 769-777.

Wong, S. H., Lui, R. N., and Sung, J. J. (2020). Covid‐19 and the digestive system. Journal of Gastroenterology and Hepatology, 35(5), 744-748.

Xiao, F., Tang, M., Zheng, X., Liu, Y., Li, X., and Shan, H. (2020). Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology, 158(6), 1831-1833.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., and Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054-1062.


Full Text: PDF

Article Metrics

Abstract View : 669 times
PDF Download : 380 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Bumi Publikasi Nusantara

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.